Q32 Bio (QTTB) Return on Sales Growth (1y) (2019 - 2024)
Q32 Bio (QTTB) Return on Sales Growth (1y) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 0.00 |
| 10 | Q32 Bio | 215.66 Mn | 164.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 51.00 |
| Jun 30, 2024 | -109.00 |
| Mar 31, 2024 | -10.00 |
| Dec 31, 2023 | 63.00 |
| Sep 30, 2023 | 32.00 |
| Jun 30, 2023 | 33.00 |
| Mar 31, 2023 | -118.00 |
| Dec 31, 2022 | -26.00 |
| Sep 30, 2022 | -21.00 |
| Jun 30, 2022 | -21.00 |
| Mar 31, 2022 | 116.00 |
| Dec 31, 2021 | 141.00 |
| Sep 30, 2021 | 69.00 |
| Jun 30, 2021 | 88.00 |
| Mar 31, 2021 | 93.00 |
| Dec 31, 2020 | -55.00 |
| Sep 30, 2020 | 40.00 |
| Jun 30, 2020 | 44.00 |
| Mar 31, 2020 | 201.00 |
| Dec 31, 2019 | -56.00 |